We show that subthreshold levels of hECSIT contribute to cardiac disease as revealed by the manifestation of cardiac hypertrophy in ECSIT+/+ mice and the association of low levels of hECSIT with myocardial hypertrophy and cardiac fibrosis in human cohorts. The gene discussed is ECSIT; the disease is cardiac hypertrophy.